1. Long-term follow-up of an IgA nephropathy cohort: outcomes and risk factors
- Author
-
Gadola, Liliana, Cabrera, María Jimena, Garau, Mariela, Coitiño, Ruben, Aunchayna, María Haydée, Noboa, Oscar, Alvarez, María Asunción, Balardini, Sylvia, Desiderio, Graciela, Dibello, Nelson, Ferreiro, Alejandro, Giró, Soledad, Luzardo, Leonella, Maino, Alfredo, Orihuela, Lucía, Ottati, María Gabriela, and Urrestarazú, Andrés
- Subjects
Nephrology ,General Medicine ,Critical Care and Intensive Care Medicine - Abstract
IgA nephropathy (IgAN), the most common glomerulopathy worldwide and in Uruguay, raised treatment controversies. The study aimed to analyze long-term IgAN outcomes and treatment. A retrospective analysis of a Uruguayan IgAN cohort, enrolled between 1985 and 2009 and followed up until 2020, was performed. The Ethics Committee approved the study. The inclusion criteria were (a) biopsy-proven IgAN; (b) age ≥12 years; and (c) available clinical, histologic, and treatment data. The patients were divided into two groups, with immunosuppressive (IS) or without (NoIS) treatment. Outcomes (end-stage kidney disease/kidney replacement therapy [ESKD/KRT] or all-cause death) were obtained from mandatory national registries. The study population included 241 patients (64.7% men), median age 32 (19.5) years, baseline blood pressure
- Published
- 2023
- Full Text
- View/download PDF